Clinical trials
Alfred Research Alliance has significant capabilities to conduct Phase I to Phase IV clinical trials, enabling us to translate discoveries into new interventions on-site.
Clinical trials are fundamental to the development of new practices, medicines and devices — improving health outcomes for all.
Alfred Health
Clinical Trials are an integral part of the research process.
Without clinical trials, new treatments and medicines cannot be approved for use in Australia.
With more than 300 open trials across 19 disease disciplines, our clinical trial portfolio is one of the largest in the country. This gives patients all over Victoria access to potentially life-saving treatments.
Baker Institute
Research projects at the Baker Institute have the potential to change the face of diabetes and heart disease prevention and management. Often, this groundbreaking research would not be possible without volunteers participating in clinical trials.
Clinical research trials at the Baker Institute may involve new drugs, devices or lifestyle strategies to help manage pre-existing medical conditions, while others may look at preventative measures to reduce the risk of disease.
Nucleus Network
Nucleus Network is Australia’s leading Clinical Research Organisation (CRO). Their 80-bed facility and services assist a global sponsor base of Biotechnology and Pharmaceutical companies. Nucleus specialises in the conduct of First-in-Human, Phase I Clinical Trials and other complex Clinical Trials including Biosimilars.
The Monash School of Public Health and Preventive Medicine
This School has substantial expertise and experience in the design, conduct and analysis of Phase 2-4 clinical trials. Led by the Monash Faculty of Medicine, Nursing and Health Sciences, and co-located at the School, the Monash University Clinical Trials Centre provides researchers with services to support clinical trial design and/or delivery.
Beyond clinical trials management, the School is home to a biostatistical team who advance the science of clinical trials, creating methodologies that enable increasingly complex trials to be run faster and cheaper. It also offers clinical trials education across short course and postgraduate formats.
The School is well-known for establishing large investigator-initiated trials, and co-ordinates industry-funded multicentre studies including:
- competitive-grant and industry-sponsored trials
- local and international trials
- hospital-based and community-based trials
- pharmacokinetic and pharmacodynamic studies
- safety and efficacy studies.
The Australian and New Zealand College of Anaesthetists (ANZCA) Trials Group
The Australian and New Zealand College of Anaesthetists (ANZCA) Trials Group aims to improve the evidence base of anaesthesia, perioperative and pain medicine by supporting multicentre research, and collaborating with other trials groups.
Members of the ANZCA Trials Group are highly skilled in the theory and practice of research methodology and have a record of success in the coordination, conduct and management large, multicentre, randomised, controlled trials.
The ANZCA Trials Group is co-located at Monash SPHPM and the Australian and New Zealand College of Anaesthetists.
360biolabs
360biolabs is Australia’s most comprehensive speciality laboratory services organisation for therapeutic, vaccine and diagnostics development.
They develop and conduct pharmacokinetic (PK) and pharmacodynamic (PD) assays across a wide variety of therapeutic areas and provide extensive support services to ensure the success of preclinical studies and clinical trials.